Epstein Secrets

e 31-Dec-14 Bloomberg EPS FY (5) 5.16 5.13 5.88 6.54 7.21 North America Equity Research 18 June 2014 Aetna J.P.Morgan Some: Company data, Bloomberg... Morgan estimates. Investment Thesis, Valuation and Risks Aetna (Overweight; Price Target: $82.00) Investment Thesis Our Overweight rating on AET

tive advantages with regard to provider network discounts and breadth, SG&A leverage, and investment spend capacity. Furthermore, WellPoint holds a Blue Cross and/or Blue Shield license in 14 states, providing the company with the strength of the Blues brand name as well as decreased competition from Not-

e mayor’ s afraid of YouTube.” (One month later, Mayor Bloomberg apparently lost that fear; by his order, the evic

y that will sound completely spontaneous. So, Kramer, what’ s your current scheme? Kramer: Okay, | got this idea because of the insurance companies. Blue Cross will pay for six Viagra pills a month. Well, that’ s very arbitrary, isn’ tit? | mean | get six hard-ons in one day. Jerry: That’ s the national ave

0.1 0.1 0.1 Utilities 0.2 0.2 0.2 0.2 S&P 500 ex. Financials & Real Estate 117.0 102.4 78.3 68.5 S&P 500 GAAP EPS impact ($9) ($8) Source: FactSet, Blaomberg, BofAML Global Research estimates, BofA Merrill Lynch US Equity & US Quant Strategy We estimate share buybacks add $4 (or as high as $6) to EPS (GAA

anizations Financial institutions and insurance 690 Exclusion of interest on bonds for private nonprofit educational facilities Education 660 Special Blue Cross/Blue Shield tax benefits Health 630 Source: BofAML US Equity & Quant Strategy, US Department of Treasury Immediate capex expensing should provide s